http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2222309-C2

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H33-04
filingDate 2002-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8c8d40d92cc8f14732a12f218e53ee4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a8f2ff5ee4c40635e9e4f45d69ece5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18cb55859e90fb6ebe5ab899ca71796b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca2e75dead064bc23b74dd271dc2c50c
publicationDate 2004-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2222309-C2
titleOfInvention Method for treating patients with psoriasis
abstract FIELD: medicine, dermatology. SUBSTANCE: patient is prescribed to take artificially prepared mud-diluting mineral baths consisting of chloride sodium salt and highly mineralized Dead Sea slime sulfide mud. Moreover, salt concentration is 30-40 g/l and 2.5- 5.0 kg mud/bath at bath's volume being 200 l at 37-38 C. Procedure lasts for 20-25 min, 4 times weekly, 14-16 procedures/course. EFFECT: prolonged period of clinical remission. 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2479302-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016113443-A1
priorityDate 2002-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11146
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID27367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452554880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14834
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID325881
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43736
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14061
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408196011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29109
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ19AZ8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280685
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R537
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451158
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCAAC63054
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID250453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559058
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2147
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559524
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395306
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29251
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8458
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18292

Total number of triples: 42.